NCT06532201

Brief Summary

This study aims to examine the effects of sujok therapy on pain, fatigue, nausea-vomiting and spiritual well-being levels in patients receiving chemotherapy. The following questions are being answered;

  • Does sujok therapy affect pain levels in cancer patients?
  • Does sujok therapy affect fatigue levels in cancer patients?
  • Does sujok therapy affect nausea-vomiting levels in cancer patients?
  • Does sujok therapy affect spiritual well-being levels in cancer patients?

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
68

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable cancer

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 1, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

August 1, 2024

Status Verified

July 1, 2024

Enrollment Period

1 month

First QC Date

July 29, 2024

Last Update Submit

July 29, 2024

Conditions

Keywords

su-jokcancer patientsPainfatiguenausea-vomitingspiritual well-being

Outcome Measures

Primary Outcomes (4)

  • "VAS" will be used to determine the pain levels of cancer patients.

    Pain levels for cancer patients

    2 months

  • "Cancer Fatigue Scale" will be used to determine the fatigue levels of cancer patients.

    Fatigue levels for cancer patients

    2 months

  • "Rhodes nausea-vomiting and retching index" will be used to determine the nausea-vomiting levels of cancer patients.

    Nausea-vomiting levels for cancer patients

    2 months

  • "Spiritual Well-Being Scale" will be used to determine the spiritual well-being levels of cancer patients.

    Spiritual well being levels for cancer patients

    2 months

Study Arms (2)

Su-jok Therapy Group /EXPERIMENTAL GROUP

EXPERIMENTAL

Su Jok will be applied to the reflection points on the hand based on the painful area of the individual. The painful areas will be determined with the applicator and black pepper seeds will be placed on these areas. Circular massage will be applied to the areas where the seeds are located for 30 minutes.

Other: Su jok seed therapy

Control Group

NO INTERVENTION

Interventions

Su Jok will be applied to the reflection points on the hand based on the painful area of the individual. The painful areas will be determined with the applicator and black pepper seeds will be placed on these areas. Circular massage will be applied to the areas where the seeds are located for 30 minutes.

Su-jok Therapy Group /EXPERIMENTAL GROUP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being over 18 years old
  • Being diagnosed with cancer
  • Being receiving chemotherapy
  • No communication problems

You may not qualify if:

  • Deterioration or death during the research process
  • Requesting to withdraw from the research
  • Incomplete filling of forms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

NeoplasmsPainFatigue

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Güzel Nur YILDIZ, Dr.

CONTACT

Arzu KARAKAYA, Specialist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

July 29, 2024

First Posted

August 1, 2024

Study Start

October 1, 2024

Primary Completion

November 1, 2024

Study Completion

January 1, 2025

Last Updated

August 1, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share